PharmaBoardroom

An insight into regulatory, pricing and reimbursement overview in Norwegian Pharma. Prepared in association with DLA Piper, a leading law firm in…

A brief overview of the situation regarding biosimilars & biologics in Singaporean Pharma. Prepared in association with Drew & Napier LLC,…

The ins and outs of orphan drugs & rare diseases in Singaporean Pharma. Prepared in association with Drew & Napier LLC, this is an extract…

Cannabinoid drugs, medicinal cannabis and opioid drugs in Singaporean Pharma - a legal guide. Prepared in association with Drew & Napier LLC,…

Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in…

Morocco, one of the most significant pharmaceutical markets in Africa, boasts a number of domestic firms. Here we highlight eight of the most…

A full list of EMA ATMP approvals. Made with Visme Infographic Maker

A full list of the cell and gene therapy products approved by the US FDA. Made with Visme Infographic Maker

A full list of the regenerative medicine products that have been approved by the PMDA, Japan's drug regulatory body. Made with Visme…

Filip Van de Vliet and Gérard Lefèbvre of Alter Pharma Group discuss the value that parallel importing is bringing to Belgian patients and the…

A comprehensive list of the new drugs approved by Japan's Pharmaceutical and Medical Devices Agency (PMDA) in 2019. Made with Visme Infographic…

Below we highlight the top 10 pharma companies in Japan based on data for 2019 sales of ethical drugs in USD billions. Japanese firms Takeda and…